Trademark: 79360545
Word
AMPHIPROTECH
Status
Registered
Status Code
700
Status Date
Tuesday, March 5, 2024
Serial Number
79360545
Registration Number
7318395
Registration Date
Tuesday, March 5, 2024
Mark Type
4000
Filing Date
Wednesday, November 30, 2022
Published for Opposition
Tuesday, December 19, 2023

Trademark Owner History
Shanghai Puyou Biomedical Co., Ltd. - Original Registrant

Classifications
5 Medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of liver diseases; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the treatment of infectious diseases, blood disorders, immune system related diseases, tumours, thyroid disease, cardiovascular and cerebrovascular diseases, inflammation and cancer; Biological preparations for medical purposes for the treatment of cancer, insomnia and heart disease; Biological preparations for medical purposes for the prevention and treatment of liver diseases; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Biological preparations for medical purposes for the prevention and treatment of gastro-intestinal diseases; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Drugs, namely, insulin for the treatment of diabetes for medical purposes; Pharmaceutical preparations, namely, analgesics, antibiotics and aspirin; Pharmaceutical preparations for the prevention and treatment of liver diseases; Pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Medicines in form of tablet form for the treatment of cancer, insomnia and heart disease; Medicines in form of tablet form for the prevention and treatment of liver diseases; Medicines in form of tablet form for the prevention and treatment of respiratory system disorders; Medicines in form of tablet form for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Medicines in form of tablet form for the prevention and treatment of gastro-intestinal diseases; Medicines in form of tablet form for the prevention and treatment of immune system related diseases and disorders; Medicines in form of tablet form for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Biochemical medicines for the treatment of cancer, insomnia and heart disease; Biochemical medicines for the prevention and treatment of liver diseases; Biochemical medicines for the prevention and treatment of respiratory system disorders; Biochemical medicines for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Biochemical medicines for the prevention and treatment of gastro-intestinal diseases; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders; Biochemical medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Capsules for medicines for the treatment of cancer, insomnia and heart disease; Capsules for medicines for the prevention and treatment of liver diseases; Capsules for medicines for the prevention and treatment of respiratory system disorders; Capsules for medicines for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, diabetes; Capsules for medicines for the prevention and treatment of gastro-intestinal diseases; Capsules for medicines for the prevention and treatment of immune system related diseases and disorders; Capsules for medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Injectable medicinal solutions, namely, dermal fillers; Injectable medicinal solutions, namely, injectable contraceptives; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purposes

Trademark Events
Mar 5, 2024
Notice Of Registration Confirmation Emailed
Mar 5, 2024
Registered-Principal Register
Dec 19, 2023
Notification Processed By Ib
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Published For Opposition
Nov 29, 2023
Notification Of Possible Opposition Sent To Ib
Nov 29, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Nov 16, 2023
Approved For Pub - Principal Register
Nov 9, 2023
Teas/Email Correspondence Entered
Nov 9, 2023
Correspondence Received In Law Office
Nov 9, 2023
Teas Response To Office Action Received
Oct 17, 2023
Refusal Processed By Ib
Sep 28, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Sep 28, 2023
Refusal Processed By Mpu
Sep 16, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 15, 2023
Non-Final Action Written
Sep 9, 2023
Assigned To Examiner
Jan 24, 2023
Application Filing Receipt Mailed
Jan 20, 2023
New Application Office Supplied Data Entered
Jan 19, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24